Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3998-4004

  Melero, Ignacio ^a   Singhal, Mitra C ^a,b   McGowan, Patrick ^a   Haugen, Harald S ^a   Blake, James ^a   Hellström, Karl Erik ^a   Yang, Guchen ^a   Clegg, Christopher H ^a   Chen, Lieping ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Darwin Molecular Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; ONCOPROTEIN;

ADOLESCENT; ANIMAL CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TRANSGENIC MOUSE; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0030899873     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3998-4004.1997     Document Type: Article

References (50)

1. Arbeit, J. M., K. Munger, P. M. Howley, and D. Hanahan. 1993. Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs. Am. J. Pathol. 142:1187-1197.
2. Arbeit, J. M., K. Münger, P. M. Howley, and D. Hanahan. 1994. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J. Virol. 68:4358-4368.
3. Arbeit, J. M., P. M. Howley, and D. Hanahan. 1996. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc. Natl. Acad. Sci. USA 93:2930-2935.
4. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, L. Van Kaer, H. P. Pircher, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651-663.
5. Auewarakul, P., L. Gissmann, and A. Cid-Arregui. 1994. Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol. Cell Biol. 14:8250-8558.
6. Borysiewicz, L. K., A. Fiander, N. Mimako, S. Man, G. W. G. Wilkinson, D. Westmoreland, A. S. Evans, M. Adams, S. N. Stacey, M. E. G. Boursnell, E. Rutherford, J. K. Hickling, and S. C. Inglis. 1996. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 347:1523-1527.
7. Chen, L., et al. Unpublished data.
8. Chen, L., S. Ashe, W. A. Brady, I. Hellstrom, K. E. Hellstrom, J. Ledbetter, P. McGowan, and P. Linsley. 1992. Costimulalion of antitumor immunity by the B7 counterreceptor for the T-lymphocyte molecules CD28 and CTLA-4. Cell 71:1093-1102.
9. Chen, L., E. K. Thomas, S. L. Hu, I. Hellstrom, and K. E. Hellstrom. 1991. Human papillomavirus type 16 nucleoprotein is a tumor rejection antigen. Proc. Natl. Acad. Sci. USA 88:110-114.
10. Chen, L., M. T. Mizuno, M. C. Singhal, S. L. Hu, D. A. Galloway, I. Hellstrom, and K. E. Hellstrom. 1992. Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J. Immunol. 148:2617-2621.
11. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellstrom, and K. E. Hellstrom. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523-532.
12. Coussens, L., D. Hanahan, and J. M. Arbeit. 1996. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol. 149:1899-1917.
13. Evans, C., S. Bauer, T. Grubert, C. Brucker, S. Baur, K. Heeg, H. Wagner, and G. B. Lipford. 1996. HLA-2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions. Cancer Immunol. Immunother. 42:151-160.
14. Falk, K., O. Rotzscheke, S. Stevanovic, G. Jung, J. G. Rammensee. 1991. Allele-specific motifs revealed by sequence of self peptides cluted from MHC molecules. Nature 351:290-296.
15. Farr, A., et al. Personal communication.
16. Feltkamp, M. C. W., H. L. Smits, M. P. M. Vierboom, R. P. Minnaar, B. M. de Jongh, J. W. Drijfhout, J. T. Schegget, C. J. M. Melief, and M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23:2242-2249.
17. Frazer, I. H., D. M. Lieppe, L. A. Dunn, A. Liem, R. W. Tindle, G. J. P. Fernando, W. C. Phelps, and P. F. Lambert. 1995. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Cancer Res. 55:2635-2639.
18. Galloway, D. A., and J. K. McDougall. 1989. Human papillomaviruses and carcinomas. Adv. Virus Res. 37:125-171.
19. Gausepohl, H., C. Boulins, W. Kraft, and R. W. Frank. 1992. Automated multiple peptide synthesis. Peptide Res. 5:315-320.
20. Greenhalgh, D. A., X. Wang, J. A. Rothnagel, J. N. Eckhardt, M. I. Quintanilla, J. L. Barber, D. S. Bundman, M. A. Longley, R. Schlegel, and D. R. Roop. 1996. Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, rasHa-activated papillomas. Cell Growth Differ. 5:667-686.
21. Griep, A. E., R. Herber, S. Jeon, J. K. Lohse, R. R. Dubielzig, and P. F. Lambert. 1993. Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J. Virol. 67:1373-1384.
22. Guerder, S., J. Meyerhoff, and R. A. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and induction and maintenance of tolerance to peripheral antigen. Immunity 1:155-166.
23. Hennings, H., D. Michael, C. Cheng, P. Steinert, K. Holbrook, and S. H. Yuspa. 1980. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254.
24. Herber, R., A. Liem, A. H. Pitot, and P. F. Lambert. 1996. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 70:1873-1881.
25. Hoffman, M. W., W. R. Heath, D. Ruschmeyer, and J. F. A. P. Miller. 1995. Deletion of high avidity T-cells by thymic epithelium. Proc. Natl. Acad. Sci. USA 92:9851-9855.
26. Hoffmann, M. W., J. Allison, and J. F. A. P. Miller. 1992. Tolerance induction by thymic medullary epithelium. Proc. Natl. Acad. Sci. USA 89:2526-2530.
27. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
28. Howley, P. M. 1989. Role of the human papillomaviruses in human cancer. Cancer Res. 51:5019s-5022s.
29. Hu, J., W. Kindsvogel, S. Busby, M. C. Bailey, Y. Shi, and P. D. Greenberg. 1993. An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues. J. Exp. Med. 177:1681-1690.
30. Inaba, K., M. Witmer-Pack, M. Inaba, K. S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P. S. Linsley, S. Ikehara, S. Muramatsu, R. J. Hodes, and R. M. Steinman. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860.
31. + cytolytic T lymphocytes. J. Exp. Med. 183:791-800.
32. Kondoh, G., Y. Murata, K. Aozasa, M. Yutsudo, and A. Hakura. 1991. Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice. J. Virol. 65:3335-3339.
33. Lambert, P. F., H. Pan, H. C. Pitot, A. Liem, M. Jackson, and A. E. Griep. 1993. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA 90:5583-5587.
34. Laufer, T. M., J. Dekonig, J. S. Markowitz, D. Lo, and L. H. Glimcher. 1996. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383:81-85.
35. Li, Y., K. E. Hellström, S. A. Ashe, and L. Chen. 1996. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors. J. Exp. Med. 183:639-644.
36. Ljunggren, H. G., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162:1745-1752.
37. 34a. Melero, I., et al. Unpublished data.
38. Moll, R., W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24.
39. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305-317.
40. Oldstone, M. B. A., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319-331.
41. Page, D. M., L. P. Kane, T. M. Onami, and S. M. Hedrick. 1996. Cellular and biochemical requirements for thymocyte negative selection. Semin. Immunol. 8:69-82.
42. Ressing, M. E., W. J. van Driel, E. Celis, A. Sette, R. M. P. Brandt, M. Hartman, J. D. H. Anholts, G. M. T. Schreuder, W. B. ter Harmsel, G. J. Fleuren, B. J. Trimbos, W. M. Kast, and C. J. M. Melief. 1996. Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A*0201-restricted E7-encoded epitope. Cancer Res. 56:582-588.
43. Romero, P., C. Pannetier, J. Herman, C. V. Jougeneel, J.-C. Cerottini, and P. G. Coulie. 1995. Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1. J. Exp. Med. 182:1019-1028.
44. Rosenberg, A. S. 1991. Skin allograft rejection, unit 4.4. In J. E. Coligan et al. (ed.), Current protocols in immunology. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
45. Seedorf, K., G. Krammer, M. Durst, S. Suhai, and W. G. Rowekamp. 1987. Identification of early proteins of the papillomaviruses type 16 (HPV16) and type 18 (HPV18) in cervical carcinoma cells. EMBO J. 6:139-144.
46. Soldevila, G., T. Geiger, and R. A. Flavell. 1995. Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen. J. Immunol. 155:5590-5600.
47. Stern, P. L. 1996. Immunity to human papillomavirus-associated cervical neoplasia. Adv. Cancer Res. 69:175-211.
48. Von Herrath, M. G., S. Guerder, H. Lewicki, R. A. Flavell, and M. Oldstone. 1995. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727-738.
49. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271:173-178.
50. zur Hausen, H. 1991. Viruses in human cancer. Science 254:1167-1173.